Daiichi Sankyo set to launch offer for 20% more in Ranbaxy
This article was originally published in Scrip
Executive Summary
Daiichi Sankyois set to launch its open offer to acquire an additional 20% stake from the shareholders of Ranbaxy Laboratorieson August 16th.